Pharmacokinetics (PK) of darunavir/ritonavir (DRV/RTV) with tenofovir DF/emtricitabine (TDF/FTC) or raltegravir (RAL) in HIV-infected adults enrolled in the NEAT001/ANRS143 study and relationship with virological response

被引：0
|
作者：
Bonora, Stefano [1 ]
Stohr, Wolfgang [2 ]
D'Avolio, Antonio [1 ]
Cursley, Adam [2 ]
Molina, Jean-Michel [3 ]
Faetkenheuer, Gerd [4 ]
Vandekerckhove, Linos [5 ,6 ]
Di Perri, Giovanni [1 ]
Pozniak, Anton [7 ]
Richert, Laura [8 ]
Raffi, Francois [9 ]
Boffito, Marta
机构：
[1] Univ Turin, Infect Dis Unit, Turin, Italy
[2] UCL, Med Res Council, London, England
[3] Univ Paris Diderot, Infect Dis, Paris, France
[4] Univ Cologne, Unit Internal Med, Cologne, Germany
[5] Univ Ghent, HIV Translat Res Unit, Ghent, Belgium
[6] Ghent Univ Hosp, Ghent, Belgium
[7] Chelsea & Westminster NHS Trust, St Stephens Ctr, London, England
[8] Univ Bordeaux, INSERIM ISPED, Bordeaux, France
[9] Nantes Univ Hosp, Infect & Trop Dis, Nantes, France
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2016年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P305
引用
收藏
页数：1
相关论文
共 10 条
  • [1] Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial
    Dickinson, Laura
    Gurjar, Rohan
    Stoehr, Wolfgang
    Bonora, Stefano
    Owen, Andrew
    D'Avolio, Antonio
    Cursley, Adam
    Molina, Jean-Michel
    Faeetkenheuer, Gerd
    Vandekerckhove, Linos
    Di Perri, Giovanni
    Pozniak, Anton
    Richert, Laura
    Raffi, Francois
    Boffito, Marta
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (03) : 628 - 639
  • [2] Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial
    Ammassari, Adriana
    Stohr, Wolfgang
    Antinori, Andrea
    Molina, Jean-Michel
    Schwimmer, Christine
    Domingo, Pere
    Thalme, Anders
    Di Pietro, Massimo
    Wallet, Cedrick
    Pozniak, Anton
    Richert, Laura
    Raffi, Francois
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2018, 79 (04) : 481 - 490
  • [3] Patient-Reported Outcomes in First-Line Antiretroviral Therapy: Results From NEAT001/ANRS143 Trial Comparing Darunavir/Ritonavir in Combination With Tenofovir/Emtricitabine or Raltegravir
    George, Elizabeth C.
    Bucciardini, Raffaella
    Richert, Laura
    Dedes, Nikos
    Fragola, Vincenzo
    Nieuwkerk, Pythia
    Spire, Bruno
    Volny-Anne, Alain
    West, Brian
    Molina, Jean-Michel
    Horban, Andrzej
    Fox, Julie
    Pozniak, Anton
    Vella, Stefano
    Termote, Monique
    Raffi, Francois
    Chene, Genevieve
    Allavena, Clotilde
    Autran, Brigitte
    Antinori, Andrea
    Arribas, Jose
    Babiker, Abdel G.
    Boffito, Marta
    Pillay, Deenan
    Franquet, Xavier
    Schwarze, Siegfried
    Grarup, Jesper
    Fischer, Aurelie
    Wallet, Cedrick
    Diallo, Alpha
    Saillard, Juliette
    Moecklinghoff, Christiane
    Stellbrink, Hans-Jurgen
    Van Leeuwen, Remko
    Gatell, Jose
    Sandstrom, Eric
    Flepp, Markus
    Babiker, Abdel G.
    Ewings, Fiona
    Hudson, Fleur
    Pearce, Gillian
    Quercia, Romina
    Rogatto, Felipe
    Leavitt, Randi
    Nguyen, Bach-Yen
    Allavena, Clotilde
    Arnault, Fabien
    Fischer, Aurelie
    Paniego, Virginie
    Schwimmer, Christine
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2018, 79 (04) : 519 - 526
  • [4] Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial
    Raffi, Francois
    Babiker, Abdel G.
    Richert, Laura
    Molina, Jean-Michel
    George, Elizabeth C.
    Antinori, Andrea
    Arribas, Jose R.
    Grarup, Jesper
    Hudson, Fleur
    Schwimmer, Christine
    Saillard, Juliette
    Wallet, Cedrick
    Jansson, Per O.
    Allavena, Clotilde
    Van Leeuwen, Remko
    Delfraissy, Jean-Francois
    Vella, Stefano
    Chene, Genevieve
    Pozniak, Anton
    LANCET, 2014, 384 (9958): : 1942 - 1951
  • [5] Changes in Cognitive Function Over 96 Weeks in Naive Patients Randomized to Darunavir-Ritonavir Plus Either Raltegravir or Tenofovir-Emtricitabine: A Substudy of the NEAT001/ANRS143 Trial
    Winston, Alan
    Stoehr, Wolfgang
    Antinori, Andrea
    Amieva, Helene
    Perre, Philippe
    De Wit, Stephane
    Reynes, Jacques
    Gompels, Mark
    Monforte, Antonella d'Arminio
    Gatell, Jose-Maria
    Grarup, Jesper
    Pozniak, Anton
    Babiker, Abdel
    Raffi, Francois
    Richert, Laura
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2017, 74 (02) : 185 - 192
  • [6] Association of SLCO1B1 521T > C (rs4149056) with darunavir/ritonavir (DRV/r) plasma concentrations in HIV-infected individuals enrolled in the NEAT001/ANRS143 study
    Gurjar, Rohan
    Boffito, Marta
    D'Avolio, Antonio
    Schwimmer, Christine
    Yazdanpanah, Yazdan
    Doroana, Manuela
    Di Perri, Giovanni
    Bonora, Stefano
    Pozniak, Anton
    Richert, Laura
    Raffi, Francois
    Owen, Andrew
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [7] Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial
    Bernardino, Jose I.
    Mocroft, Amanda
    Wallet, Cedrick
    de Wit, Stephane
    Katlama, Christine
    Reiss, Peter
    Mallon, Patrick W.
    Richert, Laura
    Molina, Jean-Michel
    Knobel, Hernando
    Morlat, Philippe
    Babiker, Abdel
    Pozniac, Anton
    Raffi, Francois
    Arribas, Jose R.
    PLOS ONE, 2019, 14 (01):
  • [8] Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial
    Bernardino, Jose I.
    Mocroft, Amanda
    Mallon, Patrick W.
    Wallet, Cedrick
    Gerstoft, Jan
    Russell, Charlotte
    Reiss, Peter
    Katlama, Christine
    De Wit, Stephane
    Richert, Laura
    Babiker, Abdel
    Buno, Antonio
    Castagna, Antonella
    Girard, Pierre-Marie
    Chene, Genevieve
    Raffi, Francois
    Arribas, Jose R.
    LANCET HIV, 2015, 2 (11): : E464 - E473
  • [9] Influence of UGT1A1 and SLC22A6 polymorphisms on the population pharmacokinetics and pharmacodynamics of raltegravir in HIV-infected adults: a NEAT001/ANRS143 sub-study
    Rohan Gurjar
    Laura Dickinson
    Daniel Carr
    Wolfgang Stöhr
    Stefano Bonora
    Andrew Owen
    Antonio D’Avolio
    Adam Cursley
    Nathalie De Castro
    Gerd Fätkenheuer
    Linos Vandekerckhove
    Giovanni Di Perri
    Anton Pozniak
    Christine Schwimmer
    François Raffi
    Marta Boffito
    The Pharmacogenomics Journal, 2023, 23 : 14 - 20
  • [10] Influence of UGT1A1 and SLC22A6 polymorphisms on the population pharmacokinetics and pharmacodynamics of raltegravir in HIV-infected adults: a NEAT001/ANRS143 sub-study
    Gurjar, Rohan
    Dickinson, Laura
    Carr, Daniel
    Stohr, Wolfgang
    Bonora, Stefano
    Owen, Andrew
    D'Avolio, Antonio
    Cursley, Adam
    De Castro, Nathalie
    Fatkenheuer, Gerd
    Vandekerckhove, Linos
    Di Perri, Giovanni
    Pozniak, Anton
    Schwimmer, Christine
    Raffi, Francois
    Boffito, Marta
    PHARMACOGENOMICS JOURNAL, 2023, 23 (01): : 14 - 20
1